Prescription Drugs - Chad

  • Chad
  • In Chad, the revenue in the Prescription Drugs market is expected to reach US$26.36m in 2024.
  • It is projected to show an annual growth rate (CAGR 2024-2029) of 2.65%, leading to a market volume of US$30.04m by 2029.
  • When compared globally, United States is expected to generate the most revenue, with US$358.90bn in 2024.
  • In terms of per person revenues, in Chad is projected to generate US$1.40 in 2024.
  • Despite being one of the poorest countries in the world, Chad has seen an increase in the availability and access to affordable prescription drugs in recent years.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Chad is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of this industry. Customer preferences in the Prescription Drugs (Pharmacies) market in Chad are shifting towards increased access and convenience. Customers are seeking out pharmacies that offer a wide range of prescription drugs to meet their healthcare needs. They also value pharmacies that provide efficient and personalized service, ensuring that they receive the correct medications and dosages. Additionally, customers are increasingly looking for pharmacies that offer affordable prices and accept various payment methods, making healthcare more accessible to a broader population. Several trends are driving the growth of the Prescription Drugs (Pharmacies) market in Chad. One key trend is the increasing prevalence of chronic diseases, such as diabetes and hypertension. As the population ages and lifestyles change, the demand for prescription drugs to manage these conditions is rising. This trend is expected to continue, driving the growth of the pharmacy market in Chad. Another trend is the expansion of pharmacy chains and the establishment of new pharmacies in urban areas. This growth is driven by the increasing urbanization and population density in Chad. As more people move to cities, the demand for pharmacies and prescription drugs is growing. Pharmacy chains are capitalizing on this trend by opening multiple locations and offering a wide range of products and services to cater to the needs of the urban population. Local special circumstances also contribute to the development of the Prescription Drugs (Pharmacies) market in Chad. The country's healthcare system is still developing, and access to healthcare services, including prescription drugs, is limited in some areas. Pharmacies play a crucial role in bridging this gap by providing essential medications and healthcare advice to the population. Additionally, the government is taking steps to improve the regulatory framework for pharmacies, ensuring that they meet quality standards and provide safe and effective medications. Underlying macroeconomic factors also play a role in the growth of the Prescription Drugs (Pharmacies) market in Chad. The country's economy is experiencing steady growth, driven by sectors such as oil and agriculture. This growth translates into increased disposable income for the population, allowing them to afford prescription drugs and healthcare services. Furthermore, the government is investing in healthcare infrastructure and initiatives to improve access to healthcare services, including pharmacies. In conclusion, the Prescription Drugs (Pharmacies) market in Chad is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As the demand for prescription drugs continues to rise, pharmacies are expanding their services and locations to meet the needs of the population. With the support of the government and favorable economic conditions, the future of the pharmacy market in Chad looks promising.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)